Health-Related Quality of Life (HRQoL) Data From KEYNOTE-412: Chemoradiotherapy (CRT) with or Without Pembrolizumab (pembro) in Patients (pts) with Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)

International Journal of Radiation Oncology*Biology*Physics Pub Date : 2024-04-01 DOI:10.1016/j.ijrobp.2024.01.091

J. Machiels, Y. Tao, B. Burtness, M. Tahara, D. Rischin, G. Alves, I. Lima, B.G.M. Hughes, Y. Pointreau, S. Aksoy, S. Laban, R. Greil, M. Burian, M. Hetnał, L. Licitra, C.M. Black, J. Norquist, B. Gumuscu, B. Bidadi, L. Siu

引用次数: 1

查看原文本刊更多论文

来自 KEYNOTE-412 的健康相关生活质量 (HRQoL) 数据：局部晚期头颈部鳞状细胞癌（LA HNSCC）患者化放疗（CRT）联合或不联合 Pembrolizumab (pembro)

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Radiation Oncology*Biology*Physics

自引率

0.00%

发文量